Cementos Bio Bio S.A. (SNSE: CEMENTOS)

Cementos Bio Bio Statistics

Total Valuation

Cementos Bio Bio has a market cap or net worth of CLP 186.28 billion. The enterprise value is 304.61 billion.

Market Cap	186.28B
Enterprise Value	304.61B

Important Dates

The next estimated earnings date is Wednesday, November 27, 2024.

Earnings Date	Nov 27, 2024
Ex-Dividend Date	Sep 23, 2024

Share Statistics

Cementos Bio Bio has 264.22 million shares outstanding. The number of shares has increased by 0.17% in one year.

Shares Outstanding	264.22M
Shares Change (YoY)	+0.17%
Shares Change (QoQ)	-3.25%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	10.92%
Float	46.70M

Valuation Ratios

The trailing PE ratio is 5.67.

PE Ratio	5.67
Forward PE	n/a
PS Ratio	0.52
PB Ratio	0.67
P/FCF Ratio	5.50
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.75, with an EV/FCF ratio of 9.00.

EV / Earnings	9.26
EV / Sales	0.84
EV / EBITDA	4.75
EV / EBIT	7.14
EV / FCF	9.00

Financial Position

The company has a current ratio of 1.59, with a Debt / Equity ratio of 47.97.

Current Ratio	1.59
Quick Ratio	0.80
Debt / Equity	47.97
Debt / EBITDA	2.05
Debt / FCF	3.89
Interest Coverage	3.37

Financial Efficiency

Return on equity (ROE) is 12.58% and return on invested capital (ROIC) is 6.84%.

Return on Equity (ROE)	12.58%
Return on Assets (ROA)	5.43%
Return on Capital (ROIC)	6.84%
Revenue Per Employee	322.30M
Profits Per Employee	29.40M
Employee Count	1,142
Asset Turnover	0.73
Inventory Turnover	3.68

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +5.97% in the last 52 weeks. The beta is 0.16, so Cementos Bio Bio's price volatility has been lower than the market average.

Beta (5Y)	0.16
52-Week Price Change	+5.97%
50-Day Moving Average	705.10
200-Day Moving Average	685.60
Relative Strength Index (RSI)	100.00
Average Volume (20 Days)	665

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cementos Bio Bio had revenue of CLP 360.65 billion and earned 32.90 billion in profits. Earnings per share was 124.31.

Revenue	360.65B
Gross Profit	139.74B
Operating Income	42.66B
Pretax Income	40.56B
Net Income	32.90B
EBITDA	53.50B
EBIT	42.66B
Earnings Per Share (EPS)	124.31

Balance Sheet

The company has 14.02 billion in cash and 131.69 billion in debt, giving a net cash position of -117.66 billion or -445.31 per share.

Cash & Cash Equivalents	14.02B
Total Debt	131.69B
Net Cash	-117.66B
Net Cash Per Share	-445.31
Equity (Book Value)	274.51B
Book Value Per Share	1,050.13
Working Capital	53.24B

Cash Flow

In the last 12 months, operating cash flow was 50.63 billion and capital expenditures -16.79 billion, giving a free cash flow of 33.85 billion.

Operating Cash Flow	50.63B
Capital Expenditures	-16.79B
Free Cash Flow	33.85B
FCF Per Share	128.10

Margins

Gross margin is 38.75%, with operating and profit margins of 11.83% and 9.12%.

Gross Margin	38.75%
Operating Margin	11.83%
Pretax Margin	11.25%
Profit Margin	9.12%
EBITDA Margin	14.83%
EBIT Margin	11.83%
FCF Margin	9.38%

Dividends & Yields

This stock pays an annual dividend of 36.00, which amounts to a dividend yield of 5.11%.

Dividend Per Share	36.00
Dividend Yield	5.11%
Dividend Growth (YoY)	200.00%
Years of Dividend Growth	n/a
Payout Ratio	28.87%
Buyback Yield	-0.17%
Shareholder Yield	4.93%
Earnings Yield	17.63%
FCF Yield	18.17%

Stock Splits

The last stock split was on July 17, 1995. It was a forward split with a ratio of 10.

Last Split Date	Jul 17, 1995
Split Type	Forward
Split Ratio	10